Cargando…

Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma

Spontaneous rupture is one of the complications of hepatocellular carcinoma (HCC) associated with a high mortality rate. Transcatheter arterial chemoembolization (TACE) has been widely used in patients with ruptured liver tumors. The aim of the present study was to evaluate the benefits and safety o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Jixue, Li, Chao, Chen, Yi, Chen, Rongxin, Xue, Tongchun, Xie, Xiaoying, Zhang, Lan, Ren, Zhenggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876292/
https://www.ncbi.nlm.nih.gov/pubmed/31807165
http://dx.doi.org/10.3892/ol.2019.11037
_version_ 1783473185470021632
author Zou, Jixue
Li, Chao
Chen, Yi
Chen, Rongxin
Xue, Tongchun
Xie, Xiaoying
Zhang, Lan
Ren, Zhenggang
author_facet Zou, Jixue
Li, Chao
Chen, Yi
Chen, Rongxin
Xue, Tongchun
Xie, Xiaoying
Zhang, Lan
Ren, Zhenggang
author_sort Zou, Jixue
collection PubMed
description Spontaneous rupture is one of the complications of hepatocellular carcinoma (HCC) associated with a high mortality rate. Transcatheter arterial chemoembolization (TACE) has been widely used in patients with ruptured liver tumors. The aim of the present study was to evaluate the benefits and safety of conventional TACE and the disease prognosis following TACE and surgery with regard to the progression of spontaneously ruptured HCC. The clinical data of 70 patients diagnosed with spontaneous rupture of HCC were retrospectively reviewed. The majority of adverse reactions that occurred following treatment were Grade 2 or below. Grade 3/4 events occurred in 20 patients (14.3%), which included gastrointestinal hemorrhage, cardiac failure, pulmonary embolism, shock and recurrent tumor rupture. All of these patients recovered and were discharged following symptomatic and supportive treatment, with the exception of two cases of severe hemorrhagic shock and hepatic failure prior to TACE treatment. These patients did not survive during the period of hospitalization. Multivariate analysis identified that a maximum tumor size >10 cm and a high serum total bilirubin level >30 µmol/l were independent factors for determining overall patient survival rate. Additionally, the overall survival rates at 1, 6 and 12 months were 92.3, 53.8 and 46.2% in the TACE group and 100, 87.1 and 54.8% in the surgery group, respectively. The overall survival rates at 1 and 6 months following TACE were lower than those of the surgery group (P<0.05). However, the overall survival rates at 12 months were similar (P>0.05). Patients in the TACE group had a shorter hospital admission compared with those in the resection group (median 7 vs. 13 days; P<0.01). Therefore, the data demonstrated that conventional TACE therapy was safe and effective for the treatment of spontaneously ruptured HCC. In addition, this type of therapy conferred a similar long-term survival rate with that of open surgery.
format Online
Article
Text
id pubmed-6876292
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-68762922019-12-05 Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma Zou, Jixue Li, Chao Chen, Yi Chen, Rongxin Xue, Tongchun Xie, Xiaoying Zhang, Lan Ren, Zhenggang Oncol Lett Articles Spontaneous rupture is one of the complications of hepatocellular carcinoma (HCC) associated with a high mortality rate. Transcatheter arterial chemoembolization (TACE) has been widely used in patients with ruptured liver tumors. The aim of the present study was to evaluate the benefits and safety of conventional TACE and the disease prognosis following TACE and surgery with regard to the progression of spontaneously ruptured HCC. The clinical data of 70 patients diagnosed with spontaneous rupture of HCC were retrospectively reviewed. The majority of adverse reactions that occurred following treatment were Grade 2 or below. Grade 3/4 events occurred in 20 patients (14.3%), which included gastrointestinal hemorrhage, cardiac failure, pulmonary embolism, shock and recurrent tumor rupture. All of these patients recovered and were discharged following symptomatic and supportive treatment, with the exception of two cases of severe hemorrhagic shock and hepatic failure prior to TACE treatment. These patients did not survive during the period of hospitalization. Multivariate analysis identified that a maximum tumor size >10 cm and a high serum total bilirubin level >30 µmol/l were independent factors for determining overall patient survival rate. Additionally, the overall survival rates at 1, 6 and 12 months were 92.3, 53.8 and 46.2% in the TACE group and 100, 87.1 and 54.8% in the surgery group, respectively. The overall survival rates at 1 and 6 months following TACE were lower than those of the surgery group (P<0.05). However, the overall survival rates at 12 months were similar (P>0.05). Patients in the TACE group had a shorter hospital admission compared with those in the resection group (median 7 vs. 13 days; P<0.01). Therefore, the data demonstrated that conventional TACE therapy was safe and effective for the treatment of spontaneously ruptured HCC. In addition, this type of therapy conferred a similar long-term survival rate with that of open surgery. D.A. Spandidos 2019-12 2019-11-01 /pmc/articles/PMC6876292/ /pubmed/31807165 http://dx.doi.org/10.3892/ol.2019.11037 Text en Copyright: © Zou et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zou, Jixue
Li, Chao
Chen, Yi
Chen, Rongxin
Xue, Tongchun
Xie, Xiaoying
Zhang, Lan
Ren, Zhenggang
Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma
title Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma
title_full Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma
title_fullStr Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma
title_full_unstemmed Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma
title_short Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma
title_sort retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876292/
https://www.ncbi.nlm.nih.gov/pubmed/31807165
http://dx.doi.org/10.3892/ol.2019.11037
work_keys_str_mv AT zoujixue retrospectiveanalysisoftranscatheterarterialchemoembolizationtreatmentforspontaneouslyrupturedhepatocellularcarcinoma
AT lichao retrospectiveanalysisoftranscatheterarterialchemoembolizationtreatmentforspontaneouslyrupturedhepatocellularcarcinoma
AT chenyi retrospectiveanalysisoftranscatheterarterialchemoembolizationtreatmentforspontaneouslyrupturedhepatocellularcarcinoma
AT chenrongxin retrospectiveanalysisoftranscatheterarterialchemoembolizationtreatmentforspontaneouslyrupturedhepatocellularcarcinoma
AT xuetongchun retrospectiveanalysisoftranscatheterarterialchemoembolizationtreatmentforspontaneouslyrupturedhepatocellularcarcinoma
AT xiexiaoying retrospectiveanalysisoftranscatheterarterialchemoembolizationtreatmentforspontaneouslyrupturedhepatocellularcarcinoma
AT zhanglan retrospectiveanalysisoftranscatheterarterialchemoembolizationtreatmentforspontaneouslyrupturedhepatocellularcarcinoma
AT renzhenggang retrospectiveanalysisoftranscatheterarterialchemoembolizationtreatmentforspontaneouslyrupturedhepatocellularcarcinoma